Thus, our data suggest that enhanced IL-6 production by CD8+ T cells may be involved in the etiology or pathogenesis of Neuro-PASC and open new avenues of research for the treatment of long COVID by blocking IL-6 activity. Here, IL6 is linked to long COVID-19.